CD8A and neoplasm: Ljujic et al., found a similar upregulation of Tregs along with a decrease in the cytotoxic capacity of CD8+ T-cells and NK cells in mice that had been co-administered 4T1 mammary carcinoma cells and hMSCs, and these effects coincided with an increase in tumour growth and metastasis.